ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $60,025,000 | +56.0% | 645,848 | -0.0% | 4.30% | +69.6% |
| Q3 2021 | $38,479,000 | -8.6% | 646,162 | +4.7% | 2.54% | +0.4% |
| Q2 2021 | $42,088,000 | +75.2% | 617,124 | +78.2% | 2.52% | +58.5% |
| Q1 2021 | $24,028,000 | -2.9% | 346,274 | +7.5% | 1.59% | -13.0% |
| Q4 2020 | $24,737,000 | +24.7% | 321,967 | +21.3% | 1.83% | -10.0% |
| Q3 2020 | $19,845,000 | +18.9% | 265,339 | +0.1% | 2.03% | +4.6% |
| Q2 2020 | $16,687,000 | +325.7% | 265,090 | +184.0% | 1.94% | +190.6% |
| Q1 2020 | $3,920,000 | -53.5% | 93,329 | -49.7% | 0.67% | -37.9% |
| Q4 2019 | $8,436,000 | -3.4% | 185,728 | -2.7% | 1.08% | -18.3% |
| Q3 2019 | $8,735,000 | +233.3% | 190,838 | +326.9% | 1.32% | +262.6% |
| Q2 2019 | $2,621,000 | – | 44,704 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |